Recent Updates
Recently added Catalysts
ATHE

ASX ANNOUNCEMENT 23 September 2022 Notice Under Section 708A(5)(e) of the Corporations Act This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ATH or Company) under section 708A(5)(e) of the Corporatio

Key Takeaway: Notice Under Section 708A(5)(e) of the Corporations This notice is given by Alterity Therapeutics Limited ACN 080 699 065 (ATH or Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act). Details of securities issued Type: Shares Class/Descriptio

Full Press Release Details

Notice Under Section 708A(5)(e) of the Corporations
This notice is given by Alterity Therapeutics Limited
ACN 080 699 065 (ATH or Company) under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act).
Details of securities issued
Type: Shares
Class/Description: Fully paid ordinary shares
ASX Code: ATH
Date of Issue: 21 September, 2022
Number Issued: 9,543,840
Issue Price per Security: AUD 0.0135
The Company gives notice pursuant to section 708A(5)(e) of
the Corporations Act that:
Alterity Therapeutics Limited
Level 3, 62 Lygon Street Carlton
Victoria 3053 Australia
Last updated: Sep 23, 2022